Page results
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a face-to-face appointment.
-
Sarah, Duchess of York, and Their Royal Highnesses Princess Beatrice and Princess Eugenie met with staff and young people in a video call to formally open the specialist haematology ward for young adults in the University College Hospital Grafton Way Building last week (Monday 11 July).
-
This page is for patients who have been referred on a suspected cancer pathway.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
Our mass vaccination centre at Bidborough House, which we have operated in partnership with UCL, closes on Friday 22 July.
-
A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.
-
This page provides details of your treatment pathway coordinator for the Teenage and Young Adult Cancer Service.
-
This page is for patients who have been referred by their GP to a gynaecology specialist because their symptoms need further tests.
-
This page tells you about having a PICC (Peripherally Inserted Central Catheter) line insertion with the Vascular Access team.
-
This booklet tells you about having a Vortex® Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
File results
-
FOI/2022/0768 - Patients treated for Haemophila A
-
FOI/2022/0681 - Deep brain stimulation procedure
-
FOI/2022/0665 - Formal patient/ family complaints
-
FOI/2022/0672 - Data Centre
-
FOI/2022/0674 - Maternity locum staffing
-
FOI/2022/0675 - Drug treatment for Paediatric patients (ages 0-16)
-
FOI/2022/0677 - Documents relating to the lift being out of order (RLHIM Lift 2 by reception)
-
FOI/2022/0679 - Theatre management, AA's and ODPs
-
FOI/2022/0696 - Trust complaints policy and discrimination and diversity policy
-
FOI/2022/0705 - Head/ neck and urothelial cancer treatment